MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2022 for Aditya R Dhoot MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2022 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2022 for Shree Rasbihari Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2022 for Ajay R Dhoot MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 02, 2022 for Ajay R Dhoot MANGALAM DRUGS & ORGANICS LTD. - 532637 - Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Jayant Barde (A61954) as a Company Secretary, Compliance Officer and Key Managerial Personnel of the Company w.e.f. Tuesday, February 8, 2022 MANGALAM DRUGS & ORGANICS LTD. - 532637 - Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021
Un-Audited Financial Results for the quarter and nine months ended December 31, 2021 MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, February 4, 2022
Outcome of Board Meeting held on Friday, February 4, 2022 MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2021(Q3) And Other Business Matters.
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2021(Q3).
